Plain-English translation of NCT07359287 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether two simple changes can help doctors prescribe antibiotics more wisely for respiratory infections like colds, bronchitis, and sinus infections. The changes involve using a special tool to help doctors talk to patients about viral infections (which don't need antibiotics), and having pharmacists review antibiotic prescriptions to make sure they're the right length. The goal is to reduce unnecessary or overly long antibiotic use, which is a major global health problem.
Antibiotics are prescribed too often and for too long, especially in primary care clinics, which is fueling antibiotic resistance — a serious threat to public health. This trial is testing whether better communication and teamwork between doctors and pharmacists can solve this problem without harming patient care.
You likely qualify if…
You likely don't qualify if…
If you are treated at one of the participating primary care clinics, you'll be part of the study automatically when you visit for a respiratory infection. Depending on which clinic you attend, your doctor may use a new tool to discuss whether you need antibiotics, and the clinic pharmacist may review your antibiotic prescription to check if the length matches current medical guidelines. You won't need extra visits — this all happens during your normal care.
AI-generated summary from trial data · Jun 8, 2026 · Not medical advice
France